Page last updated: 2024-10-30

losartan and Pleural Diseases

losartan has been researched along with Pleural Diseases in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Pleural Diseases: Diseases involving the PLEURA.

Research Excerpts

ExcerptRelevanceReference
"Pleural fibrosis is associated with various inflammatory processes such as tuberculous pleurisy and bacterial empyema."5.48Inhibition of angiotensin II and calpain attenuates pleural fibrosis. ( Greer, PA; Huang, H; Ma, WL; Shi, HZ; Song, LJ; Su, Y; Xiang, F; Xin, JB; Xiong, L; Xu, JJ; Yang, J; Ye, H; Yu, F, 2018)
"Pleural fibrosis is associated with various inflammatory processes such as tuberculous pleurisy and bacterial empyema."1.48Inhibition of angiotensin II and calpain attenuates pleural fibrosis. ( Greer, PA; Huang, H; Ma, WL; Shi, HZ; Song, LJ; Su, Y; Xiang, F; Xin, JB; Xiong, L; Xu, JJ; Yang, J; Ye, H; Yu, F, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, LJ1
Xiang, F1
Ye, H1
Huang, H1
Yang, J1
Yu, F1
Xiong, L1
Xu, JJ1
Greer, PA1
Shi, HZ1
Xin, JB1
Su, Y1
Ma, WL1

Other Studies

1 other study available for losartan and Pleural Diseases

ArticleYear
Inhibition of angiotensin II and calpain attenuates pleural fibrosis.
    Pulmonary pharmacology & therapeutics, 2018, Volume: 48

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Bleomycin; Calpain; Carbon; Cell L

2018